Stryker, Johnson & Johnson and Zimmer Biomet posted their first-quarter financial results for 2025 and data on their spine orthopedic sales.
Here is how they compare:
Total sales: $5.9 billion (+11.9%)
Orthopedics: $2.3 billion (+9.7%)
Hips: $443 million (+12.7%)
Knees: $639 million (+8.7%)
Spine: $166 million (-2.9%)
Net earnings: $654 million
Total sales: $1.9 billion (+1.1%)
Hips: $495 million (+0.9%)
Knees: $729.9 million (+0.6%)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $470.5 million (+3.9%)
Net earnings: $182 million
Medtech sales: $8 billion (+2.5%)
Orthopedic: $2.2 billion (-4.2%)
Spine, sports and other: $671 million (-10.8%)
Hips: $409 million (-3.1%)
Knees: $389 million (-3%)
Net earnings: $11 billion
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
